The_specific_activity_of_plasminogen_activator_inhibitor-1_in_disseminated_intravascular_coagulation_with_acute_promyelocytic_leukemia._In_disseminated_intravascular_coagulation_(DIC)_with_acute_promyelocytic_leukemia_(APL)_in_the_absence_of_severe_infection,_marked_fibrinolysis_was_noted_in_comparison_with_normal_levels_of_antithrombin_III,_which_is_a_major_inhibitor_of_the_coagulation_system._Increased_plasminogen_activator_inhibitor-1_(PAI-1)_antigen_levels_in_plasma_from_patients_with_septicemia_decreased_the_ratio_of_the_plasma_clot_lysis_rate_induced_by_an_anti-alpha_2-plasmin_inhibitor_monoclonal_antibody_to_the_tissue-type_plasminogen_activator_(t-PA)_concentration._This_decrease_was_not_as_prominent_in_plasma_from_patients_with_DIC,_especially_those_with_APL._To_explore_the_character_of_PAI-1_in_these_plasmas,_we_measured_the_specific_activity_of_PAI-1_by_determining_the_ratio_of_active_PAI-1_antigen_to_t-PA-unbound_PAI-1_antigen._To_calculate_the_amount_of_active_PAI-1_antigen,_the_amount_of_t-PA/PAI-1_complex_before_and_after_the_addition_of_a_fixed_amount_of_t-PA_to_the_sample_was_measured_by_a_sandwich_solid-phase_enzyme-linked_immunosorbent_assay_using_anti-PAI-1_and_anti-t-PA_monoclonal_antibodies._The_assay_to_measure_total_PAI-1_antigen_used_three_monoclonal_anti-PAI-1_antibodies_and_had_similar_sensitivities_to_free_active,_latent,_vitronectin-bound_and_t-PA-bound_PAI-1._The_specific_activity_of_PAI-1_decreased_in_patients_with_DIC_(43.7%_+/-_30.6%)_and_in_DIC_cases_with_APL_(10.3%_+/-_6.0%)_in_comparison_to_patients_with_septicemia_(83.7%_+/-_20.2%)_or_normal_controls_(85.8%_+/-_27.3%)._In_DIC_associated_with_APL,_degraded_forms_of_PAI-1_were_detected_in_plasma_by_immunoblotting._These_results_suggest_that_a_decrease_in_the_specific_activity_of_PAI-1_and_an_increase_in_secondary_fibrinolysis_result_in_a_hyperfibrinolytic_state_in_DIC_patients_with_APL.